During the past decade, Cancer Care Specialists of Illinois - Decatur conducted 224 clinical trials. In the 10-year time frame, 224 clinical trials started and 95 clinical trials were completed, i.e. on average, 42.4% percent of trials that started reached the finish line to date. In the past 5 years, 113 clinical trials started and 78 clinical trials were completed. i.e. 69% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Specialists of Illinois - Decatur" #1 sponsor was "National Cancer Institute (NCI)" with 135 trials, followed by "SWOG Cancer Research Network" with 58 trials sponsored, "Alliance for Clinical Trials in Oncology" with 38 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "NRG Oncology" with 24 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Specialists of Illinois - Decatur" #1 collaborator was "National Cancer Institute (NCI)" with 151 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 13 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Specialists of Illinois - Decatur" are "Stage IV Lung Cancer AJCC v8" (14 trials), "Recurrent Lung Non-Small Cell Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Stage IVA Lung Cancer AJCC v8" (10 trials). Many other conditions were trialed in "Cancer Care Specialists of Illinois - Decatur" in a lesser frequency.

Most popular intervention types in "Cancer Care Specialists of Illinois - Decatur" are "Drug" (219 trials), "Other" (179 trials), "Biological" (113 trials), "Procedure" (83 trials) and "Radiation" (42 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (76 trials), "Laboratory Biomarker Analysis" (74 trials), "Questionnaire Administration" (57 trials), "Computed Tomography" (45 trials) and "Biospecimen Collection" (41 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Specialists of Illinois - Decatur" are 242 trials for "All" genders, 39 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Specialists of Illinois - Decatur". undefined are not yet recruiting, 99 are recruiting, 123 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Cancer Care Specialists of Illinois - Decatur, 9 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Specialists of Illinois - Decatur, 11 "Phase 1" clinical trials were conducted, 155 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".